El Harchi Aziza, McPate Mark J, Zhang Yi hong, Zhang Henggui, Hancox Jules C
Department of Physiology and Pharmacology, and Cardiovascular Research Laboratories, School of Medical Sciences, University Walk, University of Bristol, BS8 1TD, UK.
J Mol Cell Cardiol. 2009 Nov;47(5):743-7. doi: 10.1016/j.yjmcc.2009.02.027. Epub 2009 Mar 10.
Recently identified genetic forms of short QT syndrome (SQTS) are associated with an increased risk of arrhythmia and sudden death. The SQT3 variant is associated with an amino-acid substitution (D172N) in the KCNJ2-encoded Kir2.1 K+ channel. In this study, whole-cell action potential (AP) clamp recording from transiently transfected Chinese Hamster Ovary cells at 37 degrees C showed marked augmentation of outward Kir2.1 current through D172N channels, associated with right-ward voltage-shifts of peak repolarizing current during both ventricular and atrial AP commands. Peak outward current elicited by ventricular AP commands was inhibited by chloroquine with an IC50 of 2.45 microM for wild-type (WT) Kir2.1, of 3.30 microM for D172N-Kir2.1 alone and of 3.11 microM for co-expressed WT and D172N (P>0.05 for all). These findings establish chloroquine as an effective inhibitor of SQT3 mutant Kir2.1 channels.
最近发现的短QT综合征(SQTS)的基因形式与心律失常和猝死风险增加有关。SQT3变异与KCNJ2编码的Kir2.1钾通道中的氨基酸替代(D172N)有关。在本研究中,在37摄氏度下对瞬时转染的中国仓鼠卵巢细胞进行全细胞动作电位(AP)钳记录,结果显示通过D172N通道的外向Kir2.1电流显著增强,这与心室和心房AP指令期间复极电流峰值的向右电压偏移有关。心室AP指令引发的外向电流峰值受到氯喹的抑制,野生型(WT)Kir2.1的IC50为2.45微摩尔,单独的D172N-Kir2.1为3.30微摩尔,共表达的WT和D172N为3.11微摩尔(所有P>0.05)。这些发现确立了氯喹作为SQT3突变型Kir2.1通道的有效抑制剂。